Modified Delphi Consensus Recommendations for the Management of Psoriasis in Asia–Pacific - Takeaways - MDSpire

Modified Delphi Consensus Recommendations for the Management of Psoriasis in Asia–Pacific

  • By

  • Yoo Sang Baek

  • Siew Eng Choon

  • Peter Anthony Foley

  • Tsen Fang Tsai

  • Jianzhong Zhang

  • Yukie Yamaguchi

  • July 1, 2026

  • 0 min

Share

  • 1

    Psoriasis affects approximately 43 million people globally, significantly impacting quality of life and healthcare systems in the Asia-Pacific region.

  • 2

    The study established 121 consensus statements on psoriasis management, emphasizing a patient-centered and treatment-oriented approach.

  • 3

    There are persistent gaps in psoriasis care in APAC, including inconsistent severity classification and treatment escalation criteria.

  • 4

    The modified Delphi process aimed to standardize psoriasis management across APAC, addressing regional variations in treatment eligibility and guidelines.

  • 5

    Future psoriasis care in APAC may improve with stronger local evidence, enhanced patient education, and clearer treatment thresholds.

Original Source(s)

Modified Delphi Consensus Recommendations for the Management of Psoriasis in Asia–Pacific

  • by Yoo Sang Baek, Siew Eng Choon, Peter Anthony Foley, Tsen Fang Tsai, Jianzhong Zhang, Yukie Yamaguchi

  • July 1, 2026

Related Content

Rapid Onset of Action and Quality-of-Life Improvements in Chinese Patients with Plaque Psoriasis Treated with Calcipotriol plus Betamethasone Dipropionate Aerosol Foam in a Randomized Phase 3 Trial

Guselkumab Shows Psoriasis Benefit in Darker Skin Tones

Randomized trial suggests sustained clearance across darker skin tones.

CURE: a phase-based therapeutic framework for chronic inflammation